News Center
Press Releases
- Olympus Exercises Option to Buy Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth February 26, 2021
- Even Before COVID-19, 24% Reported Putting Off Their Colonoscopy February 19, 2021
- Olympus Partners with Imbio to Bring AI-based Patient Selection Tools to Customers with SeleCT™ QCT Analysis Service February 16, 2021
- Live Remote Supervision of Neuroendovascular Surgery Enabled by Olympus MedPresence® February 11, 2021
- iTind Temporary Implant Rapidly Relieves Enlarged Prostate, Preserves Sexual Function, Says Study February 4, 2021
- Olympus PneumoLiner Is the Only 510(k)-Cleared Containment Device for Morcellation of Gynecological Tissue, as Recommended by the FDA February 3, 2021
- Olympus Launches Comprehensive Global Educational Platform for Healthcare Professionals February 1, 2021
- Olympus to Acquire Quest Photonic Devices B.V. to Bolster Surgical Endoscopy Capabilities January 28, 2021
- Olympus Expands Its Corporate Social Responsibility Efforts During COVID January 22, 2021
- New Treatment for Severe Emphysema Now Covered Under Highmark Blue Cross Blue Shield January 18, 2021
Olympus Responds
to COVID-19
Olympus is monitoring the novel coronavirus situation, in accordance with its mission of making people’s lives healthier, safer and more fulfilling around the world.
Contact Media Relations
Corporate Inquiries:
Stephanie Sherry
Vice President, Corporate Communications
Direct: (484) 896-5206
Cell: (484) 241-6465
stephanie.sherry@olympus.com
Medical and Surgical Inquiries:
Jennifer Bannan
Direct: (484) 896-6170
Cell: (412) 403-8742
jennifer.bannan@olympus.com
Scientific Solutions Inquiries:
Hilary Banda
Direct: (781) 419-3624
Cell: (339) 368-2742
hilary.banda@olympus-ossa.com
